IL10 and rheumatoid arthritis: Correspondingly, RA patient-derived MPLA-tDCs did not promote Th1 and Th17 responses, probably due to reduced IL-12p70 and IL-23 production, and the suppressive effect of other MPLA-tDC-derived molecules, such as IL-10 and TGF-β.